2019
Radiation Oncology
<
Cancer Programme
Group Leader
Manuel Ignacio Algara López
The Radiation Oncology Research Group (GREOR) is a clinical and basic research group working on the use of radiation as a base of cancer treatment, especially in the lines of altered fractionation, radiotoxicity and quality of life, technological quality control and innovation; in addition to clinical projects linked to the clinical activity in the Radiation Oncology Service.
It is a multidisciplinary group comprising medical staff, physicists, technicians and nursing staff. The group has a significant scientific output in relation to radiation oncology groups in the area, besides activity to give research visibility.
Its main objective is to maintain the active lines of research, establish synergies with other groups, both national and international, to continue with the group’s training activities and the level of scientific output, and fundraising for both competitive and non-competitive funds, besides increasing its impact in society (popular science, clinical practice guidelines, patient groups and dissemination).
Research group
Members
Enric Fernández Velilla-Ceprià (Researcher)
Palmira Foro Arnalot (Researcher)
Òscar Pera Cegarra (Researcher)
Jaume Quera Jordana (Researcher)
Anna Reig Castillejo (Researcher)
Núria Rodríguez de Dios (Researcher)
Javier Sanz Latiesas (Researcher)
Ismael Membrive Conejo (PhD Student)
M. Josefa Dengra Domingo (Technician)
Rafael Jiménez Lahuerta (Technician)
Main Publications
• Rodríguez A, Arenas M, Lara PC, López-Torrecilla J, Algara M, Conde A, Pérez-Montero H, Muñoz JL, Peleteiro P, Pérez-Calatayud MJ, Contreras J, Ferrer C, Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group. Are there enough radiation oncologists to lead the new Spanish radiotherapy? Clin Transl Oncol 2019; 21(12): 1663-1672. IF 2.441. Q3.
• Guillén A, Bofill N, Marco E, Pera O, Foro P. Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial. Trials 2019; 20(1): 503. IF 1.975. Q3.
• Carles J, Gallardo E, Doménech M, Font A, Bellmunt J, Figols M, Mellado B, Sáez MI, Suárez C, Méndez MJ, Maroto P, Luque R, de Portugal T, Aldabo R, Bonfill T, Morales-Barrera R, García J, Macià S, Maldonado X, Foro P. Phase II randomized study of radiotherapy and three-year androgen deprivation with or without concurrent weekly docetaxel in high-risk localized prostate cancer patients. Int J Radiat Oncol Biol Phys 2019; 103(2): 344-352.
Ongoing Research Projects
• Valoración de los beneficios de la rehabilitación profiláctica de la musculatura deglutoria sobre la calidad de vida y deglución, a corto y medio plazo, de los pacientes sometidos a radioterapia por cáncer de cabeza y cuello: ensayo clínico aleatorizado
- Financing institution: Fundación Asociación Española Contra el Cáncer (PS14152556FORO)
- Period: from 2015 to 2019
- Principal investigator: Foro Arnalot, Palmira
Awards
• N. Rodríguez, on behalf of GOECP/SEOR-GICOR. Randomized phase III trial of prophylactic cranial irradiation with hippocampla avoidance for small-cell lung cancer (SCLC) Best communication. XX Congress of the Sociedad Española de Oncología Radioterápica (SEOR). Santiago de Compostela, June 2019.
• Raquel Carrasco. Award for the best clinical case of the Societat Catalano-Balear d’Oncologia for the 2018-19 academic year.
C/ Doctor Aiguader, 88
08003 Barcelona
(+34) 93 316 04 00
info@imim.es